Picture of Immuneering logo

IMRX — Immuneering News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Immuneering Reports Third Quarter 2021 Financial Results

Nov 9 (Reuters) - Immuneering Corp  IMRX.O :
    * IMMUNEERING REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS
AND
RECENT BUSINESS HIGHLIGHTS
    * Q3 LOSS PER SHARE $0.47
    * EXPECTS TO FILE IND FOR IMM-1-104 IN Q1 2022

Source text for Eikon:  ID:nGNXc73Ffc 
Further company coverage:  IMRX.O 

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Immuneering

See all news